Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Accord Healthcare Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (694)
Cancellation by sponsor (84)
Prescription medicine registration (36)
Australian Public Assessment Report (AusPAR) (1)

Date

2024 (32)
2023 (81)
2022 (135)
2021 (57)
2020 (53)
2019 (102)
2018 (73)
2017 (47)
2016 (75)
2015 (65)
2014 (37)
2013 (7)
2012 (31)
2011 (20)

Results for "[search-keyword]"

Search

Sponsor content

815 result(s) found, displaying 531 to 540

Onsetron 4 mg/2 mL, Ondansetron injection, 4 mg/2 mL, Solution for injection, Glass Ampoules Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
MIDAZOLAM AN Midazolam (as hydrochloride) 5 mg/1 mL solution for injection ampoules Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
METHACCORD INJECTION methotrexate 1000mg/10mL injection vial Cancelled under Section 30(1)(c) of the Act

13 June 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
Onsetron 8 mg/4 mL, Ondansetron injection, 8 mg/4 mL, Solution for injection, Glass Ampoules Cancelled under Section 30(1)(c) of the Act

13 June 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
MIDAZOLAM AN Midazolam (as hydrochloride) 15 mg/3 mL solution for injection ampoules Cancelled under Section 30(1)(c) of the Act

13 June 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
MIDAZOLAM AN Midazolam (as hydrochloride) 50 mg/10 mL solution for injection ampoules Cancelled under Section 30(1)(c) of the Act

13 June 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
DEXMEDETOMIDINE INTAS, DEXMEDETOMIDINE ACCORD (Accord Healthcare Pty Ltd)

11 June 2019

Prescription medicine registration

Active ingredients: dexmedetomidine.
EXACCORD TABLETS 25 MG exemestane 25mg tablets blister pack Cancelled under Section 30(1) (c) of the Act

22 May 2019

Cancellation by sponsor

Requested by Accord Healthcare Pty Ltd
TERIFLUNOMIDE INTAS, TERIFLAGIO, TERINTAS (Accord Healthcare Pty Ltd)

20 May 2019

Prescription medicine registration

Active ingredients: teriflunomide.
SOLIFENACIN AMEDA, VESICAN, SOLIFENACIN GENERICHEALTH, SEFICARE, SOLIFENACIN INTAS (Accord Healthcare Pty Ltd)

20 May 2019

Prescription medicine registration

Active ingredients: solifenacin succinate.

Pages

First page
Previous page
…
Page 50
Page 51
Page 52
Page 53
Current page 54
Page 55
Page 56
Page 57
Page 58
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.